Pregabalin Capsule
Product Images NDC 71335-1792

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351792)

This is a description of Pregabalin capsules with a concentration of 150 mg. It is important to keep this and all medications out of reach of children and stored at room temperature. The NDC number for this product is 71335-1792-01, and it is made by H BRP Pharmaceuticals.*

FDA Label Image

Label (Lbl7133517922)

This appears to be prescription drug information including a comparison to Lyrica 150mg, manufacturer information, dosage information, and storage instructions. It also includes the NDC (National Drug Code) number and a caution to keep all drugs away from children.*

FDA Label Image

Logo (Logo)

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

The graph shows the percentage improvement in pain from baseline for patients taking different doses of Pregabalin and placebo. The percent of patients improved is shown on the vertical axis, while the range of daily doses is on the horizontal axis. The data indicate that the higher the daily dose of Pregabalin, the greater the percentage of patients who experienced an improvement in pain compared to placebo.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.